Fresenius SE & Co. KGaA (FRA:FRE) Trading Up 1.7% – Still a Buy?

Fresenius SE & Co. KGaA (FRA:FREGet Free Report) traded up 1.7% during mid-day trading on Friday . The company traded as high as €48.75 and last traded at €48.47. 889,446 shares were traded during trading, The stock had previously closed at €47.64.

Fresenius SE & Co. KGaA Price Performance

The stock’s fifty day moving average is €48.27 and its two-hundred day moving average is €46.76.

About Fresenius SE & Co. KGaA

(Get Free Report)

Fresenius SE & Co KGaA, a health care company, provides products and services for chronically ill patients. It operates through four segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed. The Fresenius Medical Care segment offers products and services for patients with chronic kidney failure. This segment provides dialyzers, dialysis machines, and related disposable products, as well as dialysis-related services. The Fresenius Kabi segment engages in the therapy and care of critically and chronically ill patients.

See Also

Receive News & Ratings for Fresenius SE & Co. KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius SE & Co. KGaA and related companies with MarketBeat.com's FREE daily email newsletter.